AAAAAA
Results: 1-25/113
Authors:
Diekema, DJ
Beach, ML
Pfaller, MA
Jones, RN
Citation: Dj. Diekema et al., Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America, CL MICRO IN, 7(3), 2001, pp. 152-157
Authors:
Jones, RN
Biedenbach, DJ
Johnson, DM
Pfaller, MA
Citation: Rn. Jones et al., In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent, J CHEMOTHER, 13(3), 2001, pp. 244-254
Authors:
Pfaller, MA
Citation: Ma. Pfaller, Molecular approaches to diagnosing and managing infectious diseases: Practicality and costs, EM INFECT D, 7(2), 2001, pp. 312-318
Authors:
Blumberg, HM
Jarvis, WR
Soucie, JM
Edwards, JE
Patterson, JE
Pfaller, MA
Rangel-Frausto, MS
Rinaldi, MG
Saiman, L
Wiblin, RT
Wenzel, RP
Citation: Hm. Blumberg et al., Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study, CLIN INF D, 33(2), 2001, pp. 177-186
Authors:
Diekema, DJ
Pfaller, MA
Schmitz, FJ
Smayevsky, J
Bell, J
Jones, RN
Beach, M
Citation: Dj. Diekema et al., Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999, CLIN INF D, 32, 2001, pp. S114-S132
Authors:
Pfaller, MA
Acar, J
Jones, RN
Verhoef, J
Turnidge, J
Sader, HS
Citation: Ma. Pfaller et al., Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program, CLIN INF D, 32, 2001, pp. S156-S167
Authors:
Fix, AM
Pfaller, MA
Biedenbach, DJ
Beach, ML
Jones, RN
Citation: Am. Fix et al., Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development, INT J ANT A, 18(2), 2001, pp. 141-145
Authors:
Rex, JH
Pfaller, MA
Walsh, TJ
Chaturvedi, V
Espinel-Ingroff, A
Ghannoum, MA
Gosey, LL
Odds, FC
Rinaldi, MG
Sheehan, DJ
Warnock, DW
Citation: Jh. Rex et al., Antifungal susceptibility testing: Practical aspects and current challenges, CLIN MICROB, 14(4), 2001, pp. 643-658
Cefditoren in vitro activity and spectrum: A review of international studies using reference methods
Authors:
Jones, RN
Pfaller, MA
Jacobs, MR
Appelbaum, PC
Fuchs, PC
Citation: Rn. Jones et al., Cefditoren in vitro activity and spectrum: A review of international studies using reference methods, DIAG MICR I, 41(1-2), 2001, pp. 1-14
Authors:
Richter, SS
Gordon, KA
Rhomberg, PR
Pfaller, MA
Jones, RN
Citation: Ss. Richter et al., Neisseria meningitidis with decreased susceptibility to penicillin: Reportfrom the SENTRY Antimicrobial Surveillance Program, North America, 1998-99, DIAG MICR I, 41(1-2), 2001, pp. 83-88
Authors:
Mathai, D
Jones, RN
Pfaller, MA
Citation: D. Mathai et al., Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: A report from the SENTRY Antimicrobial Surveillance Program (North America), DIAG MICR I, 40(3), 2001, pp. 129-136
Authors:
Pfaller, MA
Jones, RN
Walter, DH
Citation: Ma. Pfaller et al., Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin, DIAG MICR I, 40(1-2), 2001, pp. 67-70
Authors:
Jones, RN
Pfaller, MA
Citation: Rn. Jones et Ma. Pfaller, Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from the SENTRY Antimicrobial Surveillance Program (1997-99), DIAG MICR I, 39(4), 2001, pp. 237-243
Authors:
Biedenbach, DJ
Jones, RN
Pfaller, MA
Citation: Dj. Biedenbach et al., Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States, DIAG MICR I, 39(4), 2001, pp. 245-250
Authors:
Deshpande, LM
Jones, RN
Pfaller, MA
Citation: Lm. Deshpande et al., Accuracy of broth microdilution and E test methods for detecting chloramphenicol acetyl transferase mediated resistance in Streptococcus pneumoniae: Geographic variations in the prevalence of resistance in The SENTRY Antimicrobial Surveillance Program (1999), DIAG MICR I, 39(4), 2001, pp. 267-269
Authors:
Mathai, D
Lewis, MT
Kugler, KC
Pfaller, MA
Jones, RN
Citation: D. Mathai et al., Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I - results from the SEMTRY Antimicrobial Surveillance Program (North America, 1998) (vol 39,pg 105, 2001), DIAG MICR I, 39(4), 2001, pp. 275-275
Authors:
Mathai, D
Lewis, MT
Kugler, KC
Pfaller, MA
Jones, RN
Citation: D. Mathai et al., Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I - results from the SENTRY Antimicrobial Surveillance Program (North America, 1998), DIAG MICR I, 39(2), 2001, pp. 105-116
Authors:
Gales, AC
Biedenbach, DJ
Winokur, P
Hacek, DM
Pfaller, MA
Jones, RN
Citation: Ac. Gales et al., Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: Results from the MYSTIC Programme, DIAG MICR I, 39(2), 2001, pp. 125-127
Authors:
Jones, RN
Pfaller, MA
Stilwell, M
Citation: Rn. Jones et al., Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci, DIAG MICR I, 39(2), 2001, pp. 133-135
Authors:
Hoffman, HL
Pfaller, MA
Citation: Hl. Hoffman et Ma. Pfaller, In vitro antifungal susceptibility testing, PHARMACOTHE, 21(8), 2001, pp. 111S-123S
Authors:
Pfaller, MA
Diekema, DJ
Jones, RN
Sader, HS
Fluit, AC
Hollis, RJ
Messer, SA
Citation: Ma. Pfaller et al., International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program, J CLIN MICR, 39(9), 2001, pp. 3254-3259
Authors:
Pfaller, MA
Jones, RN
Citation: Ma. Pfaller et Rn. Jones, Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America - Authors' reply, J CLIN MICR, 39(7), 2001, pp. 2749-2750
Authors:
Dunne, WM
Kehl, KS
Holland-Staley, CA
Brueggemann, AB
Pfaller, MA
Doern, GV
Citation: Wm. Dunne et al., Comparison of results generated by serotyping, pulsed-field restriction analysis, ribotyping, and repetitive-sequence PCR used to characterize penicillin-resistant pneumococci from the United States, J CLIN MICR, 39(5), 2001, pp. 1791-1795
Authors:
Pfaller, MA
Messer, SA
Mills, K
Bolmstrom, A
Jones, RN
Citation: Ma. Pfaller et al., Evaluation of etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species, J CLIN MICR, 39(12), 2001, pp. 4387-4389
Authors:
Pfaller, MA
Messer, SA
Mills, K
Bolmstrom, A
Jones, RN
Citation: Ma. Pfaller et al., Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species, J CLIN MICR, 39(11), 2001, pp. 3952-3954